A Federal Rule Will Reverse Strides in Cancer Treatment


By Richard M. Ingram

"You've got cancer."

That's one of the scariest sentences in the English language. But it's less frightening than it used to be. Cancer death rates plummeted 29 percent between 1991 and 2017, according to the American Cancer Society. Survival rates have soared. Almost 99 percent of prostate cancer patients are still alive five years after diagnosis -- up from 68 percent in the 1970s.

We can thank cutting-edge drugs for these gains. My fellow oncologists now prescribe breakthrough medicines rather than relying on old-school chemotherapies that kill healthy cells alongside tumorous ones.

Unfortunately, the government is about to make our jobs harder -- and cut off access to cancer drugs for millions. The Centers for Medicare and Medicaid Services recently finalized a "most-favored-nation" rule, which was set to take effect on January 1.

The rule's goal is to lower drug prices for Medicare patients. But the rule is sure to backfire, with tragic consequences.

The most-favored-nation rule imposes a cap on how much Medicare will pay for 50 drugs, including many cancer treatments. The limit is pegged to the amount government health systems in other developed countries pay for those drugs.

CMS hopes this tactic will force drug makers to lower prices. That's a risky gamble. The rule notes that "some manufacturers will adhere to their current pricing instead of lowering sales prices." The rule goes on to say "this behavior may persist," and "would result in unmet demand."

Patients who need specific cancer medications won't get them. CMS assumes by 2023, 19 percent of Medicare recipients who would otherwise have received top-of-the-line therapies will not have access to them.

The rule will also jeopardize patients' access to treatment by shuttering local oncology clinics. There are more than 2,100 community cancer centers around the United States, treating 65 percent of the nation's cancer patients. These centers provide top-notch doctors, nurses, pharmacists, social workers, and financial counselors. Undergoing cancer treatment is an exhausting endeavor. These professionals make a life-or-death difference.

At my clinic, Shenandoah Oncology, we figuratively -- and often literally -- wrap our arms around patients. Our licensed clinical social workers provide emotional support to patients and families. Our pharmacists and nurse navigators guide patients through the ups and downs of treatment regimens. And our financial counselors sign patients up for assistance programs.

Drugs shrink tumors, but a full-spectrum support network enables patients to truly beat cancer.

Currently, clinics like mine buy drugs up front, administer medications, and then bill Medicare. The program reimburses us for the cost of the drugs plus a small fee to cover services provided by essential workers.

When the rule kicks in, the dollar amount of reimbursements to clinics will drop. Clinics will have to decide if they can afford to offer certain drugs. Worse, they'll have to lay off staff and cut services, if not close altogether.

Many clinics will go out of business, leaving patients with no good options. Especially in rural areas, patients might have to drive hours to find a safety-net hospital. Those hospitals rarely provide the same resources and support.

If not reversed, the most-favored-nation rule will lead to lower quality life and earlier death for thousands. We have made enormous progress in combating cancer. Let's not set it back.

Dr. Richard M. Ingram is a practicing medical oncologist and president of Shenandoah Oncology, in Winchester, Virginia. He is also president of the Virginia Association of Hematology Oncology, and volunteer on the board of directors of the Community Oncology Alliance. This piece originally ran in the Virginian-Pilot.

More Resources


03/28/2024
The Democrats' Abundance Problem Revisited
Last week, I started revisiting my "Three Point Plan to Fix the Democrats and Their Coalition" from October of 2022. A brisk tour of the polling and political data suggested the Democrats are still in need of serious reform and that the three point plan is as relevant as ever. Here's the very short version of the plan:

more info


03/28/2024
Are Democrats Still Stuck With Biden?
Voters don't think much of the president but also remain wary of the obvious replacement.

more info


03/28/2024
What the Polls Say: RFK Jr. Hurting Biden, Helping Trump
In October, when Robert F. Kennedy Jr. abandoned his primary challenge to Joe Biden and instead launched an independent candidacy, the initial conventional wisdom was that he might hurt Donald Trump more than Biden.

more info


03/28/2024
The Twilight of the Republican 'McLeadership'
The Trump team is steadily purging the Republican leadership of holdovers from past decades. The departure of McCarthy, McDaniel, and McConnell is part of exorcising the legacy of a more important Mc whose influence is still felt in the U.S. Senate: John McCain.

more info


03/28/2024
The Funniest Media Story of the Year?
The following three things were obvious before MSNBC puked on itself in its public divorce with former RNC chief Ronna McDaniel, but aren't we glad the network didn't notice? More later, but briefly:

more info


03/28/2024
Abridging, Not Coercing, Is First Amendment's Yardstick
Under the First Amendment, the government may not abridge the freedom of speech, whether that abridging is done by coercing internet platforms or by getting them to cooperate in government efforts to censor the public.

more info


03/28/2024
Trade Cheaters Are Killing Aluminum Industry Jobs
Aluminum industry workers stand ready to do their part to move the nation forward. They just need the federal government to enforce trade laws.

more info


03/28/2024
It's Time for an Immigration Moratorium
An effective freeze on immigration could revitalize our national culture, politics, and economy before it's too late.

more info


03/28/2024
U.N. Gaza Resolution Could Lead to Lasting Cease-Fire
After 171 days of a relentless Israeli assault on Gaza, the United Nations Security Council approved a resolution calling for a cease-fire in Gaza, with the United States abstaining. It's a breakthrough that must be built upon.

more info


03/28/2024
Biden's War Against the Jews
Biden claims he is a lifelong friend of the Jewish people and a Zionist, but these empty words are cover for a decades-long antipathy

more info


03/28/2024
'Fairness Initiative' Tackles Too-High Government Pay
Governments at every level ought to cap public-sector wages and benefits at private-sector comparables.

more info


03/28/2024
My Friend Joe
I write now, in the worst pain and shock, with news of my friend Joe Lieberman's death just moments ago. I write because I know what his critics will be quick to write, what news reports have already re-circulated.

more info


03/28/2024
Why I'm Resigning From the Biden State Department
Since Hamas' attack on October 7, Israel has used American bombs in its war in Gaza, which has killed more than 32,000 people - 13,000 of them children - with countless others buried under the rubble, according to the Gaza Ministry of Health. Israel is credibly accused of starving the 2 million people who remain, according to the UN special rapporteur on the right to food; a group of charity leaders warns that without adequate aid, hundreds of thousands more will soon likely join the dead.

more info


03/28/2024
Gaza: Truths Behind All the Lies
From civilian casualties, the use of disproportionate force, and international biases, the mainstream narrative of the Gaza conflict often obfuscates the truth behind lies.

more info


03/28/2024
Obama, Fearing Biden Loss to Trump, Is On Phone To Strategize
As the election approaches, President Joe Biden is making regular calls to former President Barack Obama to catch up on the race or to talk about family. But Obama is making calls of his own to Jeffrey Zients, the White House chief of staff, and to top aides at the Biden campaign to strategize and relay advice.

more info



Custom Search

More Politics Articles:

Related Articles

Every American Has Troubles


Everybody has troubles. If you don't believe it then ask any American living in the year 2020.

We Need New Antimicrobials To Prevent the Next Infectious Disease Crisis


Imagine if scientists had seen Covid-19 coming years in advance yet did little to prepare. Unthinkable, right?

I Like Ike


As other statues and monuments are being removed or criticized throughout our nation, a new $150 million memorial located near the U.S. Capitol will be dedicated Thursday honoring the general who helped defeat the Axis Powers in World War II and the president who worked diligently to preserve peace during the Cold War.

A Coronavirus Vaccine Doesn't Mean the Pandemic is Over


Dr. Anthony Fauci thinks that drug companies may develop a COVID-19 vaccine before year's end.

President Trump's Latest Executive Order Will Decimate U.S. Innovation


With only a few months left in his first term, President Trump is trying to make good on his campaign promise to lower drug prices.

A 40-Year-Old Law Continues to Produce New Jobs Today


This fall, tens of millions of Americans will get vaccinated against influenza -- but they won't all experience a prick in the arm. Instead, many will take FluMist, the painless nasal flu vaccine.

Will the Doctor See Me Now?


Imagine you're traveling out of state to visit family. When you're 15 minutes from grandma's house, you decide to let her know you'll be arriving soon.

Republican or Democrat, Foreign Reference Pricing Kills Cures


The pharmaceutical industry is on a bit of a hot streak. Just last month, both Pfizer and Moderna received FDA approval for their COVID-19 vaccines. Millions of Americans have already received them.

"March In" Is Not the Answer


All Democrats and many Republicans are committed to making prescription drugs more affordable.

Is President Biden the "Sinner-In-Chief" for Promoting Easier Access to Abortions?


Archbishop Joseph Naumann, chairman of the U.S. Conference of Catholic Bishops’ Committee on Pro-Life Activities, has taken President Biden to task for touting his faith while at the same time promoting abortions.

A Bad Means to a Bad End


What happens in a world where medical innovations like the vaccines that are defeating the coronavirus are no longer possible? That could be the result of a ham-handed effort to make America an "also-ran" country in the global pharmaceutical business.

Price Controls Happen — NOT!


The end of the pandemic is in sight, thanks in large part to the heroic efforts of the biopharmaceutical industry. American companies developed not one, but three vaccines in under a year, and roughly 3 million people are receiving those shots every day.

Foreign Drug Pricing Puts America's Most Vulnerable Patients Last


It's no coincidence that American companies led the charge to develop Covid-19 vaccines. Numerous policies -- from strong patent protections to a welcoming immigration system -- help ensure that the world's smartest scientists can pursue cutting-edge research here.

In the Fight Against Climate Change, Don't Overlook Biotech


President Biden has already laid out an ambitious climate change agenda. With a series of early executive orders, he set the stage for a ban on oil and gas drilling on federal land, an end to fossil fuel subsidies, and a transition to electric engines in government vehicles.

Don't Sabotage the Engine of American Ingenuity


It's no surprise that most of the companies behind the most effective Covid-19 vaccines are American.